Cytomegalovirus (CMV) is an important cause of morbidity and mortality in liver transplant
recipients and several different strategies of CMV chemoprophylaxis are in practice. A cost …

SUMMARY CMV is one of the most frequent viral infections after orthotopic liver
transplantation. Thus, there should be a high index of clinical suspicion, particularly in liver …

Importance of the field: Cytomegalovirus (CMV) is the most important pathogen that affects
transplant recipients, by directly causing clinical disease and by indirectly reducing patient …

Late-onset cytomegalovirus (CMV) disease remains common in CMV serology naïve kidney
transplant patients of CMV serology positive organs (D+/R–) despite the use of antiviral …

Background. The efficacy of pre-emptively administered oral ganciclovir in preventing
cytomegalovirus (CMV) disease has not been documented in liver transplant recipients. We …

Background Cytomegalovirus (CMV) infection is a serious complication following heart
transplantation. This study (June 2003–January 2010) retrospectively assessed the effects …

Background The cytomegalovirus (CMV) donor‐positive/recipient‐positive (D+/R+)
population is the largest proportion of renal transplant recipients (RTR). Guidelines for …

Background Cytomegalovirus (CMV)-seronegative kidney transplant (KTx) recipients of
organs from CMV-seropositive donors (D+/R−) are at increased risk for CMV infection …

Background: Valganciclovir prophylaxis is reportedly associated with a low incidence of
ganciclovir‐resistant cytomegalovirus (CMV). We assessed the incidence, clinical features …

Background. Cytomegalovirus (CMV) is a significant cause of morbidity, mortality, and cost
in solid organ transplant recipients. This study was conducted to measure both the clinical …